Chemical industry – Page 73
-
Business
Syngenta to cut or relocate 1800 jobs in 2015
Global reorganisation plan will involve ‘consolidation’ of R&D facilities
-
BusinessActavis rescues Allergan with $66 billion deal
Deal ends takeover fight with Valeant – but Actavis must still be ‘fairly ruthless’ to justify the high price
-
Business
Ranbaxy sues over withdrawn US approvals
Company says decision is ‘unconstitutional’ and deprives it of hundreds of millions of dollars in revenue
-
BusinessMethyl mercaptan leak kills four workers
Cause of accident at US DuPont plant is still under investigation
-
BusinessRussian sanctions hurt chemical industry
Equipment imports and modernisation hampered by extra administrative burden
-
Opinion
Good science, bad science?
Paul Leonard is concerned by industry’s exclusion from policy panels – it’s the science that matters, not who pays for it
-
Business
Labcorp to buy Covance and enter contract research
Firm wants to diversify away from diagnostics, but law firm investigation suggests investors are unconvinced of the deal’s value
-
Business
Perrigo to buy Omega Pharma for €3.6bn
Deal strengthens Perrigo’s over-the-counter portfolio and pushes strongly into Europe
-
Business
Lanxess to cut 1000 jobs over two years
Agrium also cutting 500 positions and divesting underperforming business segments
-
Business
Chinese buyer resurrects US Boehringer plant
UniTao will take over manufacturing site scheduled for closure, saving over 200 jobs
-
Business
EU warns DuPont and Honeywell over green refrigerants
Commission thinks cooperation may have been anti-competitive
-
FeatureFrom oil to chemicals
After decades of exporting oil, Saudi Arabia is looking to increase its capacity to produce chemicals. Emma Davies reports
-
Business
Judge slashes fines in drug safety case
Takeda and Eli Lilly’s $9 billion damages in diabetes trial reduced to $38 million
-
Business
Platform to expand in agrochemicals by buying Arysta
Business will be integrated with previous acquisitions for a broad crop protection portfolio
-
BusinessCHF3bn redevelopment for Roche’s Basel site
New buildings will move employees out of rented office space
-
Business
Amgen stacks up additional job cuts
Up to 1100 more staff face redundancy in ongoing restructuring plan
-
BusinessIneos bets big on shale
UK profit-sharing plan and transatlantic ethane shipping contracts show company’s commitment to a fracking future
-
Business
Amgen seeks injunction to protect patents
Sanofi and Regeneron sued over cholesterol-regulating antibodies
-
Business
Agilent to exit NMR
Closure of loss-making ex-Varian business gives users investment dilemma
-
BusinessEPA takes steps to prevent herbicide resistance in weeds
US Agency approves spray for resistant engineered crops, but with restrictions and time limit